Repeated episodes of C5a-induced neutrophil influx do not result in pulmonary fibrosis.
Multiple reactive oxygen species-induced epithelial injury by glucose, glucose oxidase, and lactoperoxidase instillation in the lung results in a progressive interstitial fibrosis. To test the hypothesis that multiple pulmonary inflammatory responses alone would not result in fibrosis, three sequential inflammatory reactions were produced at weekly intervals in hamster lungs via intratracheal instillation of human recombinant C5a. Numbers of neutrophils and total inflammatory cells in bronchoalveolar lavage (BALF) increased significantly at 24 h after each C5a treatment compared with saline controls. Neutrophils increased by 3-, 33-, and 34-fold compared with the corresponding controls at 24 h after the first, second, and third doses, respectively, but returned to control levels by six days postinstillation. LTB4 levels increased by 24% and 20% compared with the corresponding controls at 24 h after the first and second doses but were not different from controls at other times. Hydroxyproline levels in treated animals did not differ significantly from control levels throughout the study. Protein levels were significantly increased at 24 h after the second and third doses and six days after the third dose compared with the corresponding controls. Occasional foci of neutrophils in alveolar spaces were observed at 24 h after each dose, but they decreased in frequency after six days. No foci of neutrophils were observed six days after the final dose, although some epithelial degeneration was observed by transmission electron microscopy. Our results indicate that pulmonary inflammation resulting from repeated influx of neutrophils in response to multiple instillations of C5a in the lung does not cause sufficient injury to result in pulmonary fibrosis.
Harris
J A
JA
Department of Anatomy, School of Veterinary Medicine, University of California, Davis.
Hyde
D M
DM
Wang
Q J
QJ
Stovall
M Y
MY
Giri
S N
SN
D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000166:cytology; D015936:Complement C5a / Q000494:pharmacology*; D006224:Cricetinae; D006909:Hydroxyproline / Q000032:analysis; D007975:Leukotriene B4 / Q000032:analysis; D008168:Lung / Q000276:immunology; D008297:Male; D008647:Mesocricetus; D009504:Neutrophils / Q000276:immunology*; D011658:Pulmonary Fibrosis / Q000209:etiology / Q000276:immunology*
D007975:Leukotriene B4; D015936:Complement C5a; D006909:Hydroxyproline